Apimeds Pharmaceuticals US Inc
Research Apimeds Pharmaceuticals US Inc (APUS) on Bullrun: market cap USD 75.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAPUS
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 75.00M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 35.06M
- Free cash flow-USD 2.08M
Valuation Snapshot
latest market cap is USD 75.00M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 6.00M | -USD 8.98M | n/a | -0.55 | USD 1.64M | USD 7.76M | USD 153.35M |
| FY2024 | USD 0 | -USD 1.39M | -USD 733.53K | n/a | -0.18 | USD 3.46K | USD 596.84K | -USD 1.36M |
| FY2023 | n/a | -USD 777.69K | n/a | n/a | -0.17 | USD 410.48K | n/a | USD 31.87K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 75.00M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 206.25M | n/a | n/a | n/a |
About Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Apimeds Pharmaceuticals US Inc's market cap?
Apimeds Pharmaceuticals US Inc's market capitalization is USD 75.00M.
What does Apimeds Pharmaceuticals US Inc do?
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.